drugset / Trial / NCT00270088
A Study to Determine Whether Epoetin Alfa Can Reduce the Need for Blood Transfusions in Patients During the Period of Time Around Major Orthopedic Surgery.
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the safety of epoetin alfa and to determine whether epoetin alfa will reduce the need for blood transfusions during the period of time around major orthopedic surgery. Epoetin alfa is a genetically engineered protein that stimulates red blood cell production.
Timeline
- Start
- 1993-04
- Primary completion
- —
- Completion
- 1994-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | epoetin alfa | Protein / enzyme biologic | 100 iu/kg | Subcutaneous |
| Subject | epoetin alfa | Protein / enzyme biologic | 300 iu/kg | Subcutaneous |